Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology

被引:1
作者
Goedicke, Swenja [1 ,2 ]
Kresbach, Catena [1 ,2 ,3 ]
Ehlert, Max [1 ,2 ]
Obrecht, Denise [1 ]
Altendorf, Lea [1 ,2 ]
Hack, Karoline [1 ,2 ]
von Hoff, Katja [4 ,5 ,6 ]
Caren, Helena [7 ]
Melcher, Viktoria [8 ]
Kerl, Kornelius [8 ]
Englinger, Bernhard [9 ,10 ,11 ,12 ,13 ]
Filbin, Mariella [9 ,10 ]
Pajtler, Kristian W. [14 ,15 ,16 ]
Gojo, Johannes [17 ,18 ]
Pietsch, Torsten [19 ]
Rutkowski, Stefan [1 ]
Schueller, Ulrich [1 ,2 ,3 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany
[2] Res Inst Childrens Canc Ctr, Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Martinistr 52, D-20246 Hamburg, Germany
[4] Charite Univ Med Berlin, Dept Pediat Oncol & Hematol, Berlin, Germany
[5] Free Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth, Berlin, Germany
[6] Aarhus Univ Hosp, Dept Pediat & Adolescent Med, Aarhus, Denmark
[7] Univ Gothenburg, Sahlgrenska Ctr Canc Res, Dept Lab Med, Inst Biomed,Sahlgrenska Acad, Gothenburg, Sweden
[8] Univ Childrens Hosp Munster, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany
[9] Dana Farber Boston Childrens Canc & Blood Disorder, Dept Pediat Oncol, Boston, MA 02115 USA
[10] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA
[11] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, A-1090 Vienna, Austria
[12] Med Univ Vienna, Ctr Canc Res, A-1090 Vienna, Austria
[13] Med Univ Vienna, Comprehens Canc Ctr, A-1090 Vienna, Austria
[14] Hopp Childrens Canc Ctr Heidelberg KiTZ, D-69120 Heidelberg, Germany
[15] German Canc Consortium DKTK, German Canc Res Ctr DKFZ, Div Pediat Neurooncol, D-69120 Heidelberg, Germany
[16] Heidelberg Univ Hosp, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany
[17] Med Univ Vienna, Dept Pediat & Adolescent Med, Comprehens Ctr Pediat, Vienna, Austria
[18] Med Univ Vienna, Comprehens Canc Ctr, A-1090 Vienna, Austria
[19] Univ Bonn, Med Ctr, Inst Neuropathol, DGNN Brain Tumor Reference Ctr, Bonn, Germany
关键词
Ependymoma; Intratumoral heterogeneity; 1q gain; 6q loss; Morphology; DNA methylation; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR; CANCER; CLASSIFICATION; MIDKINE; PROGRESSION; RNA;
D O I
10.1007/s00401-023-02682-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posterior fossa type A (PF-EPN-A, PFA) ependymoma are aggressive tumors that mainly affect children and have a poor prognosis. Histopathology shows significant intratumoral heterogeneity, ranging from loose tissue to often sharply demarcated, extremely cell-dense tumor areas. To determine molecular differences in morphologically different areas and to understand their clinical significance, we analyzed 113 PF-EPN-A samples, including 40 corresponding relapse samples. Cell-dense areas ranged from 0 to 100% of the tumor area and displayed a higher proportion of proliferating tumor cells (p < 0.01). Clinically, cell density was associated with poor progression-free and overall survival (pPFS = 0.0026, pOS < 0.01). Molecularly, tumor areas with low and high cell density showed diverging DNA methylation profiles regarding their similarity to distinct previously discovered PF-EPN-A subtypes in 9/21 cases. Prognostically relevant chromosomal changes at 1q and 6q showed spatial heterogeneity within single tumors and were significantly enriched in cell-dense tumor areas as shown by single-cell RNA (scRNA)-sequencing as well as copy number profiling and fluorescence in situ hybridization (FISH) analyses of different tumor areas. Finally, spatial transcriptomics revealed cell-dense areas of different tumors to be more similar than various different areas of the same tumor. High-density areas distinctly overexpressed genes encoding histone proteins, WNT5A, TGFB1, or IGF2. Relapsing tumors displayed a higher proportion of cell-dense areas (p = 0.036), a change in PF-EPN-A methylation subtypes (13/32 patients), and novel chromosome 1q gains and 6q losses (12/32 cases) compared to corresponding primary tumors. Our data suggest that PF-EPN-A ependymomas habor a previously unrecognized intratumoral heterogeneity with clinical implications, which has to be accounted for when selecting diagnostic material, inter alia, by histological evaluation of the proportion of cell-dense areas.
引用
收藏
页数:16
相关论文
共 47 条
  • [1] EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
    Antin, C.
    Tauziede-Espariat, A.
    Debily, M. -A.
    Castel, D.
    Grill, J.
    Pages, M.
    Ayrault, O.
    Chretien, F.
    Gareton, A.
    Andreiuolo, F.
    Lechapt, E.
    Varlet, P.
    [J]. ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [2] Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q
    Baroni, Lorena, V
    Sundaresan, Lakshmikirupa
    Heled, Ayala
    Coltin, Hallie
    Pajtler, Kristian W.
    Lin, Tong
    Merchant, Thomas E.
    McLendon, Roger
    Faria, Claudia
    Buntine, Molly
    White, Christine L.
    Pfister, Stefan M.
    Gilbert, Mark R.
    Armstrong, Terri S.
    Bouffet, Eric
    Kumar, Sachin
    Taylor, Michael D.
    Aldape, Kenneth D.
    Ellison, David W.
    Gottardo, Nicholas G.
    Kool, Marcel
    Korshunov, Andrey
    Hansford, Jordan R.
    Ramaswamy, Vijay
    [J]. NEURO-ONCOLOGY, 2021, 23 (08) : 1360 - 1370
  • [3] Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas
    Bayliss, Jill
    Mukherjee, Piali
    Lu, Chao
    Jain, Siddhant U.
    Chung, Chan
    Martinez, Daniel
    Sabari, Benjamin
    Margol, Ashley S.
    Panwalkar, Pooja
    Parolia, Abhijit
    Pekmezci, Melike
    McEachin, Richard C.
    Cieslik, Marcin
    Tamrazi, Benita
    Garcia, Benjamin A.
    La Rocca, Gaspare
    Santi, Mariarita
    Lewis, Peter W.
    Hawkins, Cynthia
    Melnick, Ari
    Allis, C. David
    Thompson, Craig B.
    Chinnaiyan, Arul M.
    Judkins, Alexander R.
    Venneti, Sriram
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (366)
  • [4] Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: literature review
    Bienkowski, Michal
    Preusser, Matthias
    [J]. CURRENT OPINION IN NEUROLOGY, 2015, 28 (06) : 647 - 658
  • [5] Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells
    Binda, Elena
    Visioli, Alberto
    Giani, Fabrizio
    Trivieri, Nadia
    Palumbo, Orazio
    Restelli, Silvia
    Dezi, Fabio
    Mazza, Tommaso
    Fusilli, Caterina
    Legnani, Federico
    Carella, Massimo
    Di Meco, Francesco
    Duggal, Rohit
    Vescovi, Angelo L.
    [J]. CANCER RESEARCH, 2017, 77 (04) : 996 - 1007
  • [6] DNA methylation-based classification of central nervous system tumours
    Capper, David
    Jones, David T. W.
    Sill, Martin
    Hovestadt, Volker
    Schrimpf, Daniel
    Sturm, Dominik
    Koelsche, Christian
    Sahm, Felix
    Chavez, Lukas
    Reuss, David E.
    Kratz, Annekathrin
    Wefers, Annika K.
    Huang, Kristin
    Pajtler, Kristian W.
    Schweizer, Leonille
    Stichel, Damian
    Olar, Adriana
    Engel, Nils W.
    Lindenberg, Kerstin
    Harter, Patrick N.
    Braczynski, Anne K.
    Plate, Karl H.
    Dohmen, Hildegard
    Garvalov, Boyan K.
    Coras, Roland
    Hoelsken, Annett
    Hewer, Ekkehard
    Bewerunge-Hudler, Melanie
    Schick, Matthias
    Fischer, Roger
    Beschorner, Rudi
    Schittenhelm, Jens
    Staszewski, Ori
    Wani, Khalida
    Varlet, Pascale
    Pages, Melanie
    Temming, Petra
    Lohmann, Dietmar
    Selt, Florian
    Witt, Hendrik
    Milde, Till
    Witt, Olaf
    Aronica, Eleonora
    Giangaspero, Felice
    Rushing, Elisabeth
    Scheurlen, Wolfram
    Geisenberger, Christoph
    Rodriguez, Fausto J.
    Becker, Albert
    Preusser, Matthias
    [J]. NATURE, 2018, 555 (7697) : 469 - +
  • [7] The role of the extracellular matrix protein TGFBI in cancer
    Corona, Armando
    Blobe, Gerard C.
    [J]. CELLULAR SIGNALLING, 2021, 84
  • [8] Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study
    Donson, Andrew M.
    Bertrand, Kelsey C.
    Riemondy, Kent A.
    Gao, Dexiang
    Zhuang, Yonghua
    Sanford, Bridget
    Norris, Gregory A.
    Chapman, Rebecca J.
    Fu, Rui
    Willard, Nicholas
    Griesinger, Andrea M.
    de Sousa, Graziella Ribeiro
    Amani, Vladimir
    Grimaldo, Enrique
    Hankinson, Todd C.
    Booker, Ffyona
    Sill, Martin
    Grundy, Richard G.
    Pajtler, Kristian W.
    Ellison, David W.
    Foreman, Nicholas K.
    Ritzmann, Timothy A.
    [J]. NEURO-ONCOLOGY, 2023, 25 (10) : 1854 - 1867
  • [9] Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target
    Filippou, Panagiota S.
    Karagiannis, George S.
    Constantinidou, Anastasia
    [J]. ONCOGENE, 2020, 39 (10) : 2040 - 2054
  • [10] MYCN amplification drives an aggressive form of spinal ependymoma
    Ghasemi, David R.
    Sill, Martin
    Okonechnikov, Konstantin
    Korshunov, Andrey
    Yip, Stephen
    Schutz, Peter W.
    Scheie, David
    Kruse, Anders
    Harter, Patrick N.
    Kastelan, Marina
    Wagner, Marlies
    Hartmann, Christian
    Benzel, Julia
    Maass, Kendra K.
    Khasraw, Mustafa
    Straeter, Ronald
    Thomas, Christian
    Paulus, Werner
    Kratz, Christian P.
    Witt, Hendrik
    Kawauchi, Daisuke
    Herold-Mende, Christel
    Sahm, Felix
    Brandner, Sebastian
    Kool, Marcel
    Jones, David T. W.
    von Deimling, Andreas
    Pfister, Stefan M.
    Reuss, David E.
    Pajtler, Kristian W.
    [J]. ACTA NEUROPATHOLOGICA, 2019, 138 (06) : 1075 - 1089